pharmaphorum

Data builds on Roche's dominance in primary progressive MS

Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...
pharmaphorum

Roche's oral MS hope fenebrutinib hits the mark in phase 3

Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Investopedia

Net Worth Averages by Age Show Where You Really Stand Compared to Your Peers

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Getty Images Net worth is a clear way ...
Healthline

7 Ways Brussels Sprouts May Benefit Your Health

Brussels sprouts are a source of fiber, vitamin K, and vitamin C. They can help support blood clotting, bone strength, immune function, and digestion. The antioxidants in Brussels sprouts help protect ...